ADMA: Three White Soldiers detected on 7 Aug 2026

ADMA is forming a three-white-soldiers bullish continuation pattern as of August 7, 2026—two days after reporting Q2 2026 earnings with $124.4 million revenue. The stock sits at $10.06, just below immediate resistance at $10.35. The pattern structure scores a perfect 15/15, reflecting three consecutive higher closes with strong internal mechanics. Breakout strength (10.4/13) and volume (10.8/12) are solid; current volume of 5.6M shares is 2.04x the 20-day average, confirming institutional participation. RSI at 72.35 signals overbought conditions. The conservative target sits at $10.70, a modest 6.4% move above current price.

Q2 2026 revenue of $124.4 million increased 2% year-over-year, with ASCENIV revenue growing 24% year-over-year to $102.9 million. June delivered the strongest sequential month-over-month ASCENIV utilization growth since the first half of 2024. The company is on track for 2026 revenue guidance of $530M–$560M and plans to repurchase at least $200 million of shares. However, revenue and earnings estimates have declined significantly over the past 90 days—full-year 2026 revenue expectations fell from $634.65M to $559.50M, and earnings estimates dropped from $0.98 to $0.81 per share. Additionally, a securities fraud class action lawsuit has been filed focusing on alleged misrepresentations concerning financial condition, revenue recognition, inventory distribution, and business practices.

A successful breakout above $10.35 resistance would target $10.70 on the conservative measure—achievable within 3-5 trading sessions given current volume momentum. Volume confirmation requires maintaining the elevated 2.0x multiple seen in recent days; a pullback accompanied by diminishing volume below 2M shares would weaken conviction. The setup invalidates decisively if price closes below $8.16 key support, which represents a 19% downside risk from current levels. Win probability of 54.85% indicates this is a marginal-alpha setup; the pattern suggests slightly better odds than a coin flip, but meaningful conviction is limited.

Critical near-term risks include: (1) RSI at 72.35 signals overbought conditions, elevating pullback risk after a 16% one-week and 20% two-week gain; (2) a securities class action lawsuit with an August 10, 2026 lead plaintiff deadline creates headline and litigation risk overhang; (3) significant downward estimate revisions over 90 days suggest deteriorating analyst sentiment on growth trajectory; (4) the conservative 6.4% target provides limited reward-to-risk ratio against the $8.16 support level; (5) beta of 0.14 suggests defensive characteristics that may underperform if broader biotech momentum accelerates elsewhere.

We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading.